Information was received from a healthcare provider (hcp) regarding a patient who was receiving morphine (5 mg/ml at.4964 mg/day), bupivacaine (5 mg/ml at.4964 mg/day), and clonidine (400 mcg/ml at 39.72 mcg/day) via an implantable pump for unknown indications for use.It was reported that in (b)(6) 2021 the patient had a refill and there were residual fluid and also some bubbles.The hcp stated that at the end of the aspiration there was a small amount of yellowish fluid. the hcp stated that the pump was then refilled, hours later the patient was seen again because they were concerned about getting overdosed.The hcp reported that they aspirated the pump and there was no volume discrepancy.The hcp stated that the patient had 2 refills following this with no issues.At the patient's last refill on (b)(6) 2022 they noted a small amount of yellow fluid again with no volume discrepancy and filled the pump.8 hours post refill, the patient overdosed and felt dizzy, uncoordinated, dry mouth, and a little sleepy.The hcp stated that the symptoms subsided with no treatment.Of note, the patient had gained weight so it is a little difficult to access.
|